IRIS UniCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.160
EU - Europa 1.145
AS - Asia 680
SA - Sud America 136
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.140
IT - Italia 326
SG - Singapore 248
SE - Svezia 221
CN - Cina 204
DE - Germania 183
BR - Brasile 119
IN - India 81
IE - Irlanda 80
FR - Francia 67
GB - Regno Unito 55
FI - Finlandia 53
ID - Indonesia 53
UA - Ucraina 48
RU - Federazione Russa 30
KR - Corea 29
NL - Olanda 21
AT - Austria 15
BE - Belgio 15
HK - Hong Kong 11
CA - Canada 10
IR - Iran 8
PH - Filippine 8
TR - Turchia 8
AR - Argentina 7
PL - Polonia 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
ES - Italia 6
JP - Giappone 6
VN - Vietnam 6
MA - Marocco 4
BD - Bangladesh 3
IQ - Iraq 3
MX - Messico 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AW - Aruba 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
GF - Guiana Francese 2
HR - Croazia 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.144
Salva come PNG Salva come JPEG
Città #
Chandler 272
Singapore 157
Ashburn 126
Rome 116
Dublin 76
Hyderabad 57
Ann Arbor 54
Jakarta 49
Milan 45
New York 44
San Mateo 40
Helsinki 35
The Dalles 33
Wilmington 29
Jacksonville 27
Boston 26
Hefei 26
Seoul 23
Frankfurt am Main 22
Moscow 22
Nanjing 22
Princeton 20
Cattolica 19
Marseille 18
Beijing 17
Dearborn 17
Los Angeles 17
Bari 14
Boardman 13
Brussels 13
Vienna 12
Lawrence 11
London 11
Munich 11
Nürnberg 11
Fairfield 10
Hong Kong 10
Nuremberg 10
Leawood 9
Seattle 9
São Paulo 9
Woodbridge 9
Redwood City 8
Washington 8
Bremen 7
Düsseldorf 7
Houston 7
Abidjan 6
Bexley 6
Council Bluffs 6
Lauterbourg 6
North Bergen 6
Andover 5
Augusta 5
Islington 5
Izmir 5
Mountain View 5
Naples 5
Toronto 5
Turin 5
Amsterdam 4
Brasília 4
Brooklyn 4
Changsha 4
Genazzano 4
Hangzhou 4
Lappeenranta 4
Madrid 4
Newark 4
Paris 4
Portsmouth 4
San Francisco 4
Shanghai 4
Zhengzhou 4
Campinas 3
Des Moines 3
Detroit 3
Edinburgh 3
Falkenstein 3
Hebei 3
Jeju City 3
Martellago 3
Nanchang 3
Norwalk 3
Oliveri 3
Olomouc 3
Phoenix 3
Redmond 3
Rio de Janeiro 3
Roubaix 3
Sanford 3
Sanremo 3
Santa Clara 3
Turku 3
Wuhan 3
Zugliano 3
Ardabil 2
Asti 2
Atlanta 2
Auckland 2
Totale 1.808
Salva come PNG Salva come JPEG
Nome #
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 138
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 134
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 125
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 115
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 90
Targeting the hallmarks of ovarian cancer: The big picture 88
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 86
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 84
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 83
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 80
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 79
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 79
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 77
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 75
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 75
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 75
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 69
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 68
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 68
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 66
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 66
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 62
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 62
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 60
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 57
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 56
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 56
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 54
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 53
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 53
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 52
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 51
Newly diagnosed ovarian cancer: Which first-line treatment? 51
PARP Inhibitors Resistance: Mechanisms and Perspectives 50
Recent progress in the use of pharmacotherapy for endometrial cancer 48
Minilaparoscopic Aortic Lymphadenectomy 47
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 46
Advanced and recurrent endometrial cancer: State of the art and future perspectives 45
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 42
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 42
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique 41
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 39
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 38
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 38
Management of stage III and IVa uterine cancer 37
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 36
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 34
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 32
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 26
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 22
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 16
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres 16
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 13
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 13
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 11
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 9
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 4
Totale 3.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 0 0 13
2020/2021143 15 12 6 10 18 8 9 5 14 10 29 7
2021/2022312 12 13 4 24 18 5 15 55 15 27 49 75
2022/2023737 93 96 52 115 37 91 34 53 74 16 32 44
2023/2024523 12 116 23 47 26 57 43 33 5 30 65 66
2024/20251.143 39 28 96 60 91 63 63 50 153 168 311 21
Totale 3.232